Lohoff, F W <br/><br/>
Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.  [electronic resource] 

 -  The pharmacogenomics journal  Oct 2013 
 - 464-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2012.33  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents--therapeutic use<br/>Anxiety Disorders--drug therapy<br/>Biomarkers, Pharmacological--metabolism<br/>Cyclohexanols--therapeutic use<br/>Double-Blind Method<br/>Haplotypes<br/>Humans<br/>Pharmacogenetics--methods<br/>Polymorphism, Single Nucleotide<br/>Receptor, Serotonin, 5-HT2A--genetics<br/>Serotonin Plasma Membrane Transport Proteins--genetics<br/>Venlafaxine Hydrochloride<br/>White People--genetics